Fiduciaries considering alternatives would need to evaluate them “objectively, thoroughly and analytically” against factors such as performance, fees, liquidity, valuation, benchmarks and complexity. That effectively codifies what due diligence on alternatives should look like under ERISA and creates a framework that carriers and managers will need to reflect in product design, disclosure and ongoing support.
